UNCY Reports $57.1M Cash, $1.6M R&D Expenses, $(0.54) EPS, OLC NDA Review On Track
Unicycive Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $7.60
-6.6% in 7d after detection
Post-detection moves
1h
—
1d
+4.2%
3d
+1.1%
7d
-6.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS